Analysts Have Conflicting Sentiments on These Real Estate Companies: Federal Realty (FRT) and Sabra Healthcare REIT (SBRA)
Companies in the Real Estate sector have received a lot of coverage today as analysts weigh in on Federal Realty (FRT – Research Report) and Sabra Healthcare REIT (SBRA – Research Report).
Valentine's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Federal Realty (FRT)
Scotiabank analyst Greg McGinniss maintained a Buy rating on Federal Realty today and set a price target of $113.00. The company’s shares closed last Thursday at $104.75.
According to TipRanks.com, McGinniss is a 2-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Federal Realty with a $111.50 average price target, a 3.3% upside from current levels. In a report issued on February 2, BMO Capital also maintained a Buy rating on the stock with a $120.00 price target.
See the top stocks recommended by analysts >>
Sabra Healthcare REIT (SBRA)
Scotiabank analyst Nicholas Yulico maintained a Hold rating on Sabra Healthcare REIT today and set a price target of $20.00. The company’s shares closed last Thursday at $20.25.
According to TipRanks.com, Yulico is a 3-star analyst with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Sabra Healthcare REIT with a $21.00 average price target, which is a 6.9% upside from current levels. In a report released today, BMO Capital also maintained a Hold rating on the stock with a $22.00 price target.
